Our Approach
CompliScience Solutions provides science-based, regulator-aligned consulting services to support the development of clinical-stage biopharmaceutical, biologics, cell and gene therapy, and advanced therapeutic products from early development through late-phase clinical readiness.
Clinical-stage development sits at the critical intersection of science, regulation, and manufacturing. Decisions made during this phase directly impact product quality, regulatory credibility, and long-term commercial viability. We help clients translate product science and development risk into practical, defensible CMC, cGMP, and regulatory strategies that support efficient clinical progression and future scale-up.
Our team brings hands-on experience leading CMC and MS&T organizations, developing clinical manufacturing processes, building analytical and control strategies, and supporting FDA interactions and inspection readiness for IND-enabling and clinical programs.
Our support includes:
oIND-enabling CMC and cGMP strategy
oPhase-appropriate quality system development
oProcess development, scale-up, and tech transfer
oAnalytical method development and qualification
oControl strategy and specification development
oProcess characterization and risk assessment
oClinical manufacturing readiness
oCDMO selection and oversight support
oINTERACT, Pre-IND, and regulatory meeting preparation
Rather than treating clinical development as an isolated phase, we apply a lifecycle approach that aligns early development decisions with long-term regulatory and commercial expectations.
The result is a streamlined, inspection-ready development strategy that reduces risk, strengthens data integrity, and supports successful clinical advancement.
